Studies of the L1210 antileukemic activity of O-2,2'-cyclocytidine, monoacetate (anhydro-ara-C; NSC-129220)--comparison with cytosine arabinoside (NSC-63878) with respect to treatment schedule dependency.
D000085:Acetates / Q000008:administration & dosage / Q000627:therapeutic use; D000284:Administration, Oral; D000818:Animals; D003500:Cyclization; D003561:Cytarabine / Q000008:administration & dosage* / Q000627:therapeutic use; D003562:Cytidine / Q000008:administration & dosage* / Q000627:therapeutic use; D004351:Drug Resistance; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D007939:Leukemia L1210 / Q000188:drug therapy*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains
D000085:Acetates; D003561:Cytarabine; D003562:Cytidine